This is ideal for the AD animal model in rats as it induces chronic neuroinflammation, memory and cognitive impairment, and development of tau and Aβ pathology after the intraventricular administration (Nazem et al. 2015). The gene discussed is MAPT; the disease is Alzheimer disease.